Background: Fine-needle aspiration (FNA) cytology has been the standard of care in the workup of cervical lymph nodes (LNs) in patients with recurrent papillary thyroid cancer (PTC) and suspicious cervical LNs. Recently, FNA thyroglobulin (TG) washout measurement has been proposed as an adjunct in the management of these patients. We hypothesize that using FNA-TG washout for suspicious cervical LNs would increase the accuracy of diagnosing metastatic disease especially in cystic and highly vascular cervical LN in patients with recurrent PTC. Methods: This is a retrospective study of a prospectively collected database for patients with thyroid cancer who underwent preoperative FNA followed by selective neck dissection by one surgeon at an academic institution. FNA-cytology and FNA-TG washout were performed simultaneously. A total of 138 patients were included in our study, of which 92 (66.7%) had undergone surgical intervention. Results of both methods were then correlated with the final surgical pathology. Results: FNA-cytology alone showed a sensitivity of 80.0%, specificity of 100.0% with a negative predictive value (NPV) of 60.0%. By contrast, FNA-TG washout had a sensitivity of 95.8%, specificity of 90.5% with a NPV of 86.4%. Combination of the FNA-cytology with FNA-TG washout of cystic/highly vascular LN increased the accuracy of diagnosis with a sensitivity of 98.2%, specificity of 100.00% with a NPV of 95.0%. All 14 malignant cervical LNs with false-negative FNA-cytology showed elevated FNA-TG washout, 10 (71.4%) of which were cystic in nature and 4 were highly vascular on ultrasonography. Conclusion: FNA-TG washout increases the diagnostic accuracy in detecting metastatic disease in patients with recurrent thyroid cancer. FNA-TG washout may be of special diagnostic importance in cystic or highly vascular LNs, which might have falsely negative cytology. Level of Evidence: 2B K E Y W O R D S cystic lymph nodes, papillary thyroid cancer, thyroglobulin washout, vascular lymph nodes
| INTRODUCTION
In North America, the incidence of thyroid cancer is increasing by over 6% per year. 1 Papillary thyroid cancer (PTC) is the most common malignancy of the thyroid, making up 75-85% of all thyroid cancers. 2 PTCs have increased significantly from 58% in 1970-1980 to 85.9% of thyroid cancers in 2000-2010. 1, 3 Cervical lymph node involvement has been reported to be as high as 46% at initial diagnosis, 4 but with proper treatment, prognosis is generally good and long-term survival is expected. Despite the favorable outcome with treatment, up to 20% of patients are still at risk of local or regional recurrence after initial surgery. 2, 5 Until recently, ultrasonography and fine-needle aspiration (FNA) cytology have been standard diagnostic modalities used to detect and evaluate cervical LN in patients with metastatic disease. Despite the presence of specific characteristics of malignancy on ultrasound, such as peripheral vascularization, cystic appearance, and loss of hilum, 6 some studies have shown it to have a low specificity (37%) for the reason that benign lymphadenopathies are extremely frequent. 7, 8 FNA-cytology has also been shown to have a disappointing sensitivity (76%) with a high rate of nondiagnostic samples and a negative predictive value (NPV) of 34.7%. 9, 10 Recently, the thyroglobulin (TG) measurement in FNA washout fluids (FNA-TG) has proven to be a useful tool in the management of patients with recurrent PTC, especially cystic LNs. The cystic nature of the LN as well as highly vascular LNs has made it difficult to extract enough cells to be adequate for cytological examination. Hence, the adjunct use of directly measuring the concentration of TG in the washout has been proposed to improve the diagnostic yield of cytology in such cases. We hypothesized that for patients referred for surgical intervention for recurrent PTC, FNA-TG washout testing, in addition to routine cytological examination, will yield a higher degree of accuracy in diagnosing metastatic cystic/highly vascular LN cervical disease.
| PATIENTS AND METHODS
This is a level 2b retrospective data analysis was performed on a prospectively collected database on patients referred for surgical evaluation of thyroid disease at Tulane Medical Center. A total of 138 patients (106 women and 32 men) who had previously undergone a total thyroidectomy with suspicious lymph nodes were referred for surgical consultation between March 2008 and February 2015. Patients with positive findings on FNA-cytology or FNA-TG washout underwent central and/or selective lateral neck dissection. Otherwise, patients were followed up with repeat comprehensive neck ultrasound and serum TG panels every 6 months. All patients with thyroid cancer at our institution were treated with levothyroxine in doses that were intended to suppress serum TSH levels. Suspicious cystic/highly vascular LNs detected on ultrasound were biopsied, and specimens were assessed via FNA-cytology and FNA-TG washout that was performed routinely in the same sitting by the same surgeon.
| FNA-cytology
Material was obtained by ultrasound-guided FNA performed by a single surgeon using a 25-gauge needle and a 10 mL syringe. Direct smears were prepared from needle aspirates, stained with the Diff-Quik method, and reviewed for immediate on-site evaluation. The wet-fixed (alcohol-fixed) smears were also prepared and stained with the Papanicolaou method in the cytopathology laboratory. The final cytological diagnosis was made through the evaluation of both types of smears.
| FNA-TG measurement
After the needle aspirates were smeared directly on glass slides for cytological examination as described above. The needle was then washed with 1 mL of saline solution. Specimens were immediately transferred to the clinical laboratory and stored at −20 C for up to 4 days before TG analysis. TG concentrations were measured using an automated immunochemiluminometric assay (Beckman Coulter Access/Access 2 Immunoassay System; Beckman Coulter Inc, Brea, California) with an analytical sensitivity of 0.1 ng/mL. Data on suspicious findings seen on the ultrasound examination were collected. We considered a TG cutoff value of 1 ng/mL as positive for metastatic disease, which has been supported by numerous studies 4, 11 and validated by a recent robust meta-analysis that evaluated cutoff values between 0.2 and 50 ng/mL. 12 Results of both FNA-cytology and FNA-TG washout were then correlated with the final surgical pathology. For the association of selected variables with final LN finding, Chi-square test for the categorical variables and two-tailed student's t test for the continuous variables were applied. In examining the validity of FNA-TG washout and FNA-cytology, the following parameters were calculated: sensitivity, specificity, accuracy, and negative and positive predictive values. Kappa statistics were also performed when looking into the agreement between FNA-TG washout and FNA-cytology.
| RESULTS
The mean age at time of surgical referral was 53.1 AE 14.2 years (Table 1) . Of the 138 patients included in our study, 46 patients had negative FNA-cytology and FNA-TG washout results and were followed with comprehensive neck ultrasound with an average follow-up time of 29.7 AE 9.2 months. Ninetytwo patients underwent surgical intervention due to either positive FNA-cytology, FNA-TG washout or both. Forty-one patients of these had a selective lateral neck dissection, 41 had a central lymph node dissection (CLND), 6 had a selective neck dissection in addition to CLND, 3 had a redo selective lateral neck dissection, and 1 had a redo CLND. FNA-cytology revealed that 77 (100%) patients had true positive results, which were confirmed by surgical lymph node pathology, 14 patients (40%) diagnosed with the disease based on surgical lymph node pathology results tested negative via FNA-cytology. FNA-cytology did not reveal any false-positive results. FNAcytology alone revealed a sensitivity of 80% and specificity of 100% with a NPV of 60%. Evaluation of the FNA-TG washout alone revealed more accurate results compared to cytological evaluations alone. All metastatic cervical lymph nodes had higher FNA-TG washout values with a mean of 2600.59 AE 7108.75 ng/mL. When utilizing the data from the FNA-TG washout, only two patients (2.8%) had a false-positive finding. FNA-TG washout showed a sensitivity of 95.8% and a specificity of 90.5%. All 14 malignant cervical LNs (100%) with falsenegative FNA-cytology showed elevated TG washout. When combining FNA-cytology and FNA-TG washout, 54 patients (100%) had true positive results whereas 19 (95%) had true negative results, and 1 (5%) had a false-negative result. Using FNA-TG washout as an adjunct to FNA-cytology resulted in 98.2% sensitivity, 100% specificity with a NPV of 95% (See Table 2 ).
Interestingly, 10 of 14 (71.4%) malignant cervical LNs that had elevated TG washout and negative FNA-cytology are cystic in nature and the remaining 4 (28.5%) were highly vascular on preoperative ultrasonography.
As predicted, serum TG in metastatic cervical LN had higher TG values compared to benign cervical LN 85.07 AE 143.9 ng/mL and 5.24 AE 10.03. Serum TG ranged from less than 0.1-38.2 ng/mL in benign LN and less than 0.1-868 ng/mL in metastatic LN (Figure 1 ). Although there was no correlation between FNA-TG washout and serum TG concentrations, nearly all benign LN had FNA-TG washout levels below the corresponding serum TG. All but four metastatic LN had more FNA-TG washout than serum, often with many orders of magnitude difference. Only four malignant LN had undetectable serum TG; however, the corresponding FNA-TG washout levels were 16, 23, 120, and 147 ng/mL. Serum TG values to final histopathological results are plotted in Figure 1 .
The mean FNA-TG washout to serum Tg ratio for benign cervical LN is 0.58 AE 0.93 and 195.03 AE 503.63 for malignant cervical LN; however, both FNA-TG washout and serum TG are not normally distributed with many outliers which make their interpretation difficult. Thus, a correlation coefficient analysis was done to better report how these two variables relate. There was a significant direct correlation, (Pearson's coefficient 0.69, P < .001) when evaluating FNA-TG washout-serum TG ratio to malignancy. FNA-TG washout-serum TG ratio to final histopathological results is plotted in Figure 2 .
| DISCUSSION
Either normal thyrocytes or well-differentiated thyroid cancer cells usually produce TG. Serum TG levels after thyroid surgery and radioiodine ablation have been used to indicate the presence of metastatic disease or residual benign thyroid tissue. This is often a deciding factor in determining whether a diagnostic or therapeutic procedure should be undertaken. It has been recommended by the American Thyroid Association that serum TG levels as well as comprehensive neck ultrasonography is periodically checked in patients who have undergone thyroid cancer surgery. Serum TG levels can also be elevated in patients with previous thyroid-preserving surgery such as lobectomy, subtotal thyroidectomy, or total thyroidectomy without subsequent RAI ablation, as these patients are thought to have remnant thyroid tissue without tumor recurrence. 13 FNA-cytology has been an acceptable modality that has demonstrated a high diagnostic accuracy of tumor recurrence and cervical lymph node metastasis, but has resulted in false-negative as well as non-diagnostic results in up to 20% of cases.
2,10,14 FNA-TG washout measurement is an easy and inexpensive technique that can be added as an adjunct to FNA-cytology. FNA-TG washout was initially introduced by Pacini et al. in 1992 for the early detection of neck lymph node metastasis in patients with differentiated thyroid cancer. 9 Low TG levels that are still high enough to be differentiated from nonthyroidal diseases are generally found in patients with differentiated thyroid cancer. 15 Nevertheless, our current study confirmed that FNA-TG washout would increase the reliability and specificity of fine-needle biopsy. Our study showed that measurement of FNA-TG washout is an excellent tool for detecting metastatic disease in patients with recurrent PTC in cervical lymph nodes with cystic component and significant internal vascularity. For 14 LNs, the disease was not detected by FNA-cytology, but was identified by FNA-TG washout. We found that all 14 LNs were either cystic or highly vascular lymph nodes; this is most likely due to the inability to extract enough cells on aspiration due to the nature of the lymph node.
On the contrary, we have observed two patients without LN metastasis who were seen with detectable FNA-TG washout levels. The reason for this falsely elevated FNA-TG washout was not clear. Anti-thyroglobulin autoantibodies (TgAb) are known to interfere with serum TG [15] [16] [17] ; however, multiple studies have demonstrated that TgAb have shown no effect on the sensitivity of FNA-TG levels. 2, 7, 18 It has been reported that very high TGAB levels in FNA-TG fluid may decrease the TG level below the diagnostic threshold, hence a false-negative result. 19 Some labs have chosen to flag patients with high-titer TGAB who are at risk for falsely low TG levels in FNA-TG. 19, 20 Only 8 patients (5.8%) in our cohort had elevated TgAb, and due to this small sample size, we were unable to draw any statistical interpretations. This is the largest American series reported with results similar to the rate reported in previous studies 14, 21 and reflects the challenge in diagnosing cystic cervical lesions with FNA-cytology. Our study showed that combination of FNA-cytology and FNA-TG washout has been shown to attain higher specificity and sensitivity than the conventional method, with a NPV of 95% and a diagnostic accuracy of 98.6% in patients with recurrent well-differentiated thyroid cancer. FNA-TG cutoff values for the detection of recurrences/ metastases in lymph nodes are still controversial. More recent studies have investigated the ratio between FNA-TG washout and serum TG to further potentiate the diagnostic accuracy. It has been reported that by using ratios of FNA-TG and serum LN, discrepancies related to confounding factors such as assay, needle, washout solution, tube, and unit of TG can be improved. Lee et al. proposed that, in the absence of a thyroid gland, FNA-TG washout to serum TG cutoff ratio of 1 showed a diagnostic performance of 100%. 22 We as well found a significant direct correlation, (r = 0.69, P < .001) when evaluating FNA-TG washoutserum TG ratio to malignancy. The United States healthcare system is under increased scrutiny to exercise judicious ordering of cost-effective tests while maintaining optimal patient care. Chung et al. suggested only ordering FNA-TG with 1 or 2 suspicious ultrasound features; however, not in LNs with multiple suspicious findings. 23 Baldini et al. suggested collecting FNA-TG levels from all FNA specimens, but only performing the testing on cases with inadequate cytology or inconsistent results based on clinical suspicion. 20 Since the FNA-TG washout would be collected in advance, and can be stored up to 1 year if kept at −20 C before being analyzed. This would allow the practitioner to review the FNA-cytology results and if deemed necessary can have the FNA-TG washout analysis performed; potentially sparing the patient from needing another biopsy. However, the cost of FNA-TG washout is $97 at our institution which is less expensive than cytology ($325).
As this was a retrospective study, we encountered some limitations. We were unable to exclude false-negative determination of FNA-TG washout, as the patients with a negative LN cytology and an undetectable FNA-TG washout did not undergo LN surgery, and therefore determination of false-negative results cannot be excluded. However, we are confident that these are true negative since all patients who did not undergo an operation were followed up every 6 months with a comprehensive neck ultrasound and serum TG panels. Our average follow-up for the current study is 29.7 months; therefore, as none of those patients progressed over this period, we can assume that they were in fact true negatives.
In conclusion, FNA-TG washout in adjunct to FNAcytology is a valuable tool for detecting metastatic disease in patients with recurrent PTC. Patients with cystic and/or highly vascular LNs would benefit the most from adding FNA-TG washout examination, which might have falsely negative cytology, hence judicious performance of USguided FNA-TG washout as an adjunct to FNA-cytology should be considered in these patients.
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